Quantum Biopharma (QNTM) Cash from Operations (2019 - 2026)

Quantum Biopharma has disclosed Cash from Operations across 7 years of filings, most recently posting 1668749.0 for Q1 2026.

• Cash from Operations for Q1 2026 came in at 1668749.0, up 60.84% year-over-year; the trailing twelve-month figure through Mar 2026 was 5644918.0 (up 38.4% YoY), and the FY2025 annual result was 8237012.0, down 19.79% from the prior year.
• Cash from Operations came in at 1668749.0 for Q1 2026 at Quantum Biopharma, down from 305598.0 in the prior quarter.
• In the past five years, Cash from Operations ranged from a high of 9398050.0 in Q2 2022 to a low of 50340664.0 in Q4 2022.
• The 4-year median for Cash from Operations is 1668749.0 (2026), against an average of 3470424.08.
• Across the five-year window, Cash from Operations soared 63.85% in 2022 and sank 221.38% in 2025, its largest moves.
• Quantum Biopharma's Cash from Operations stood at 50340664.0 in 2022, then jumped by 98.34% to 835762.0 in 2024, then surged by 63.43% to 305598.0 in 2025, then tumbled by 446.06% to 1668749.0 in 2026.
• The last three Cash from Operations figures came in at 1668749.0 (Q1 2026), 305598.0 (Q4 2025), and 1721476.0 (Q3 2025), per Business Quant data.